MedPath

Low-level Laser Therapy in the Treatment of Chronic Periodontitis in Type 2 Diabetics

Not Applicable
Completed
Conditions
Chronic Periodontitis
Diabetes Mellitus
Interventions
Procedure: Periodontal ultrasonic debridement
Device: Debridement plus low-level laser therapy
Registration Number
NCT02817152
Lead Sponsor
Universidade Estadual Paulista Júlio de Mesquita Filho
Brief Summary

The aim of this study was to investigate the local effect of adjunct low-level laser therapy (LLLT) for the treatment of moderate to severe chronic periodontitis in type 2 diabetic patients.

Detailed Description

The aim of this study was to investigate the local effect of adjunct low-level laser therapy (LLLT) for the treatment of moderate to severe chronic periodontitis in type 2 diabetic patients. Twenty poorly-controlled type 2 diabetic patients with moderate to severe generalized chronic periodontitis were selected. Two periodontal pockets with Probing Depth (PD) and Clinical Attachment Level (CAL) ≥ 5mm received ultrasonic periodontal debridement (UPD) only (control group) or UPD with LLLT (test group). Clinical measures, such as PD, CAL, Gingival Recession (GR), Bleeding on Probing (BoP), and Plaque Index (PI), were collected and compared at baseline, 30, 90, and 180 days. The adjunct application of LLLT to UPD had no additional benefits for PD reduction and CAL gain, meaning that both investigated therapies were efficient for the treatment of chronic periodontitis in type 2 diabetics. Nevertheless, additional LLLT application showed better results for GR then UPD only.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • age ≥ 35; diagnosis of type 2 diabetes for ≥ 5 years; diabetes treatment with oral hypoglycemic agents or insulin supplementation and diet; glycated hemoglobin (HbA1c) levels from 6.5% to 11%; at least 15 teeth (excluding third molars and teeth indicated for extraction); and moderate to severe generalized chronic periodontitis.
Exclusion Criteria
  • The exclusion criteria were: medical conditions that required prophylactic antimicrobial coverage; periodontal mechanical therapy in the previous 6 months; antimicrobial therapies in the previous 6 months; anti-inflammatory therapies in the previous 6 months; systemic conditions other than diabetes that could affect the progression of chronic periodontitis; current use of medication that could interfere with periodontal response to treatment; pregnancy or lactation; and smoking.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Periodontal ultrasonic debridementPeriodontal ultrasonic debridementPeriodontal pockets received ultrasonic periodontal debridement intervention.
Low-level laser therapyDebridement plus low-level laser therapyPeriodontal pockets received ultrasonic periodontal debridement plus low-level laser therapy intervention.
Low-level laser therapyPeriodontal ultrasonic debridementPeriodontal pockets received ultrasonic periodontal debridement plus low-level laser therapy intervention.
Primary Outcome Measures
NameTimeMethod
Probing depth change from baseline to 30, 90, and 180 days through periodontal probingbaseline, 30 days, 90 days, 180 days
Secondary Outcome Measures
NameTimeMethod
Clinical attachment level change from baseline to 30, 90, and 180 days through periodontal probingbaseline, 30 days, 90 days, 180 days
Bleeding on probing change from baseline to 30, 90, and 180 days through periodontal probingbaseline, 30 days, 90 days, 180 days
Gingival recession change from baseline to 30, 90, and 180 days through periodontal probingbaseline, 30 days, 90 days, 180 days
Plaque index change from baseline to 30, 90, and 180 days through periodontal probingbaseline, 30 days, 90 days, 180 days
© Copyright 2025. All Rights Reserved by MedPath